GL1X · GenesisL1 explorer

MolNFT v1 · #123096 · protein

Crystal structure of CPT1691 bound to TAK1-TAB1

5J9L · Mitogen-activated protein kinase kinase kinase 7,TGF-beta…: “Crystal structure of CPT1691 bound to TAK1-TAB1”. X-ray diffraction, 1 ligand (6HF), 3 pockets (best druggability 0.55). MolNFT v1 #123096 on GenesisL1: 3D structure…

PDB
5J9L
Type
protein
Length
286 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Mitogen-activated protein kinase kinase kinase 7,TGF-beta- activated kinase 1 and…
EC
2.7.11.25
UniProt
O43318, Q15750
Ligands
6HF
Pockets
3 · best druggability 0.55

Structure

x-ray diffraction · 1 distinct chain · 40% helix, 13% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMitogen-activated protein kinase kinase kinase 7,TGF-beta- activated kinase 1 and MAP3K7-binding protein 1 (EC 2.7.11.25)protein28640% helix, 13% strandO43318, Q15750

Ligands and binding sites

  • 6HF · N-(4-((2-((4-(4-methylpiperazin-1-yl)phenyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)phenyl)acrylamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11530.550.80186HF
21250.390.7425empty
3680.310.7419empty

Compared structures

  • 5J9L · Crystal structure of CPT1691 bound to TAK1-TAB1 · the same entry in another collection · chain A against A, TM-score 1.00
  • O43318 · AlphaFold monomer V2.0 prediction for mitogen-activated protein kinase kinase kinase 7… · a predicted model of the same protein · chain A against A, TM-score 0.93
  • Q15750 · AlphaFold monomer V2.0 prediction for TGF-beta-activated kinase 1 and MAP3K7-binding… · a predicted model of the same protein · chain A against A, TM-score 0.31

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.